NIH-funded research R21 grant

Lower Airway Microbes and Oxidative Stress in Inflammatory Lung Disease

Official title: Lower Airway Microbial Sulfur Metabolism and Oxidative Stress in Inflammatory Lung Disease

Funded at New York University School of Medicine · NIH-11356103 · Data updated 2026-11-12

A study to understand how microbes in the lungs influence oxidative stress and inflammation in lung diseases, with a focus on how smoking-related damage and sulfur compounds affect patients.

More Oxidative Stress research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startMay 20, 2026
Project endApril 30, 2028
Funding year2026
Award (this year)$254,250
NIH project number1R21AI199100-01
Project IDNIH-11356103 on NIH RePORTER

Who could benefit from this research

Could help

Adults with inflammatory airway diseases (e.g., COPD) and variations in lung microbiome and oxidative stress markers.

Less likely to help

Individuals without inflammatory airway disease or those not experiencing oxidative stress-related pathology may see limited relevance.

What this research studies

This project will look at how the bacteria living in the lungs contribute to redox balance and inflammation in lung diseases. Using measurements of oxidative stress markers and lung microbiome profiles, researchers will explore how microbial metabolites and sulfur chemistry relate to disease severity. The goal is to map connections between lung microbes, sulfur compounds, and lung function to identify potential pathways for therapy. The work is designed with patient relevance in mind, aiming to uncover targets that could lead to better management of inflammatory airway diseases.

Why it matters

Potential benefit: If successful, the findings could inform new approaches to reduce oxidative damage and improve lung function in patients with inflammatory airway diseases.

How similar studies have gone: Prior research shows the lung microbiome can influence lung metabolism and inflammation, suggesting this approach may yield meaningful insights.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Wong, Kendrew King Hao — New York University School of Medicine
  • Study coordinator: Wong, Kendrew King Hao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.